Market capitalization | €67.25m |
Enterprise Value | €55.47m |
P/E (TTM) P/E ratio | 13.37 |
P/B ratio (TTM) P/B ratio | 1.09 |
Revenue (TTM) Revenue | €0.00 |
EBIT (operating result TTM) EBIT | €-613.00k |
EPS (TTM) EPS | €0.88 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast 2invest:
1 Analyst has issued a forecast 2invest:
Jun '24 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -0.61 -0.61 |
-
|
Net Profit | 5.03 5.03 |
-
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
2invest AG is a holding company, which engages in life sciences field and is primarily active in the areas of immunology, proteomics and genomics. Its products include antibody and protein conjugation; assays; DNA/RNA isolation and amplification; and mass spectrometry. The company was founded in 1997 and is headquartered in Heidelberg, Germany.
Head office | Germany |
CEO | Hansjörg Plaggemars |
Employees | 3 |
Founded | 1997 |
Website | www.sygnis.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.